Article Versions Notes

Carazo F, Bértolo C, Castilla C, Cendoya X, Campuzano L, Serrano D, Gimeno M, Planes FJ, Pio R, Montuenga LM, et al. DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC). Cancers. 2020; 12(7):1824. https://doi.org/10.3390/cancers12071824

Carazo, Fernando, Cristina Bértolo, Carlos Castilla, Xabier Cendoya, Lucía Campuzano, Diego Serrano, Marian Gimeno, Francisco J. Planes, Ruben Pio, Luis M. Montuenga, and et al. 2020. "DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC)" Cancers 12, no. 7: 1824. https://doi.org/10.3390/cancers12071824

Carazo, F., Bértolo, C., Castilla, C., Cendoya, X., Campuzano, L., Serrano, D., Gimeno, M., Planes, F. J., Pio, R., Montuenga, L. M., & Rubio, A. (2020). DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC). Cancers, 12(7), 1824. https://doi.org/10.3390/cancers12071824